Confirm licensing, credentialing, and payer enrollment transfer
Clinical practices depend on provider credentials, facility licenses, and payer contracts that may not pass to a new owner; verify before close.
health care and fitness business for Sale in Tennessee
Similar businesses sell at 1.2x to 6.3x SDE. Compare live listings and connect with sellers.
12 results
Medical Practices
Medical Practices
Growing Outpatient Psychiatric Practice located in Nashville Suburb
Nashville, Davidson County, Tennessee, United States
Nashville, Davidson County, TN, US
New opportunity to acquire a respected outpatient psychiatric practice in a rapidly growing Nashville suburb, generating $465,000 annually. Specializing in personalized care for anxiety, depression, bipolar disorder, trauma, ADHD, and adjustment disorders, the practice employs a client-centered approach, crafting tailored treatment plans to support patient wellbeing. The modern 2,300 sq. ft. facility includes 7 consultation rooms, advanced telehealth capabilities, an integrated EMR system, and a balanced payor mix with strong insurance relationships. Staffed by a dedicated team of mental health professionals and support personnel committed to staying, the practice ensures seamless operations. The new owner can capitalize on the area’s rising demand for mental health care. Perfect for a psychiatrist, mental health group, or investor seeking a stable practice with significant growth potential. Contact [email protected] for confidential inquiries or detailed financials upon after executing a NDA.
$400,000
$466,909Revenue
$110,400Cash Flow
Other Health Care & Fitness
Other Online & Technology
Other Health Care & Fitness
+1
Bio Technology Company
Tennessee, United States
TN, US
This firm develops life science research tools enabling autonomous, non-invasive, real-time monitoring of compound bioavailability, biological events, or viability/metabolic dynamics from any cell using a proprietary synthetic luciferase technology that does not require external stimulation to function. The Company’s products are immediately relevant to discovery phase pharmacology programs as an improved method for accessing the toxicity and metabolic impact of potential new drug compounds and to in vitro and in vivo basic research and development activities for interrogating tumor formation, progression, and recession, cellular health, motility, localization, or transcriptional activity. Their patent protected synthetic luciferase removes the need for external stimulation that limits current fluorescent and bioluminescent imaging approaches. Unlike previous technologies, it can automatically turn on or off light production to indicate biomarker transcription or changes in differentiation state, continuously emit harmless visible light to enable persistent localization and viability tracking, or autonomously adjust signal intensity to reflect real-time changes in metabolism, toxicity, or any other desired cellular metric. This solves the problems of uneven excitation and emission in 3D culture applications, allows the distribution, health, and propagation of implanted cells to be tracked in real-time in small animal models, and removes the need to sacrifice precious in vitro samples concurrent with luciferin exposure. As a simple genetic technology, their synthetic luciferase can be delivered using the same transfection approaches as older fluorescent/luminescent genes and expression can be regulated using any transcriptional or synthetic biology control architecture. This drop-in replacement capability, combined with improved functionality, enables exciting new capabilities, and accelerates existing research by producing more data, reducing costs, and enabling continuous automated tracking without requiring perturbation at any point throughout the data collection process. The purchase of this company includes patents, ready-to-ship product inventory, the bacterial stocks required to make more of the products, all scientific lab notebooks from R&D operations, and company intelligence data. The value is based on the "cost to recreate" and projections based on requests. The products are ready for orders and in demand by some of the world’s largest biotech companies and most respected researchers. This company has recently completed the vetting process to have their products featured in the Thermo Fisher Scientific catalogue. A key element necessary for growth and marketing of the products is an experienced business development team. Orders can be worth $1mm each large client within the first 5 years.
$5,000,000
$826,081Revenue
$33,031Cash Flow
Market Snapshot
National transaction benchmarks for health care and fitness business businesses.
Under $500K
Median revenue$390k
Median cash flow$100k
Median sale price$165k
Multiple range1.2x - 2.5x
$500K to $2M
Median revenue$1.34m
Median cash flow$338k
Median sale price$900k
Multiple range2.2x - 3.6x
Over $2M
Median revenue$5.66m
Median cash flow$900k
Median sale price$5.04m
Multiple range3.7x - 6.3x
A variety of factors can cause businesses to trade outside this range, including earnings quality, operational transferability, key-person risk, growth trajectory, and geography, so a listing priced above or below the typical multiple usually reflects real differences in the underlying business.
What to know about health care and fitness business acquisitions
GW
Cofounder & CEO
Key diligence, valuation, financing, and transition considerations for buyers evaluating health care and fitness business acquisitions.
Understand the payer and reimbursement mix
A practice heavy in one insurer or in declining reimbursement carries different risk than cash-pay or membership; get revenue by payer and the trend.
Quantify provider and owner dependence
The dentist, physician, or lead trainer often is the practice — know who holds the patients or members and what non-competes are in place.
Separate recurring memberships from fee-for-service
Gyms live on retention; high churn behind a growing top line is a warning. Get gross and net retention, not sign-ups.
Review compliance and liability standing
HIPAA, billing audits, malpractice history, and inspections are real liabilities; confirm coverage and open matters.
Assess equipment, facility, and deferred capital
Clinical equipment and fitness build-outs age and date — and a gym relocation alone can run $100K–$500K. Budget what's been deferred.
Frequently Asked Questions
Answers to common buyer questions for this market.
Yes, helped by recurring revenue. Lenders weigh provider transfer, payer concentration, and credentialing, so a practice that runs beyond the owner funds most easily.